• About
    ▼
    • Overview
    • Leadership
    • Our Team
    • Board of Directors
    • Investors
  • Science
    ▼
    • Overview
    • Highly Cytotoxic T Cells
    • KLRG1
    • Publications
  • Pipeline
    ▼
    • Overview
    • ABC008
    • IBM
    • T-LGLL
    • Additional Indications
    • ABC015
  • News
  • Careers
  • Contact
About

About

Abcuro

Breakthrough Therapies for Autoimmune Diseases & Cancer

  • About
    • Overview
    • Leadership
    • Our Team
    • Board of Directors
    • Investors
  • Science
    • Overview
    • Highly Cytotoxic T Cells
    • KLRG1
    • Publications
  • Pipeline
    • Overview
    • ABC008
    • IBM
    • T-LGLL
    • Additional Indications
    • ABC015
  • News
  • Careers
  • Contact

Deptula-Hicks, Darlene

March 7, 2022

Ms. Deptula-Hicks currently serves as F-star’s Chief Financial Officer. In addition, Darlene has operated Crimson Advisors, a strategic and financial consulting services company, and has served as acting Chief Financial Officer for Northern Biologics as well Senior Vice President and Chief Financial Officer of T2 Biosystems. Previously she was Senior Vice President and Chief Financial Officer of Pieris Pharmaceuticals and Vice President and Chief Financial Officer of Microline Surgical.  Darlene currently also serves on the board of directors and as audit committee chair of Aerami Therapeutics and previously served on the board of directors and as audit committee chair of Giner Life Sciences, Xentic Biosciences, and IMCOR Pharmaceuticals. Darlene received an M.B.A. from Rivier University and a B.S in Accounting from Southern New Hampshire University.

Darlene Deptula-Hicks

Chief Financial Officer,
F-star Therapeutics

x

Darlene Deptula-Hicks

Chief Financial Officer,
F-star Therapeutics

Ms. Deptula-Hicks currently serves as F-star’s Chief Financial Officer. In addition, Darlene has operated Crimson Advisors, a strategic and financial consulting services company, and has served as acting Chief Financial Officer for Northern Biologics as well Senior Vice President and Chief Financial Officer of T2 Biosystems. Previously she was Senior Vice President and Chief Financial Officer of Pieris Pharmaceuticals and Vice President and Chief Financial Officer of Microline Surgical.  Darlene currently also serves on the board of directors and as audit committee chair of Aerami Therapeutics and previously served on the board of directors and as audit committee chair of Giner Life Sciences, Xentic Biosciences, and IMCOR Pharmaceuticals. Darlene received an M.B.A. from Rivier University and a B.S in Accounting from Southern New Hampshire University.

Privacy Site Credits Terms of Use

© 2023 Abcuro